id,agency_id,docket_id,title,document_type,subtype,posted_date,posted_year,posted_month,comment_start_date,comment_end_date,last_modified,fr_doc_num,open_for_comment,withdrawn,object_id
FDA-2016-E-0617-0007,FDA,FDA-2016-E-0617,Letter from FDA CDER to the U.S. Patent and Trademark Office,Other,Letter(s),2017-09-20T04:00:00Z,2017,9,2017-09-20T04:00:00Z,,2017-09-20T13:39:18Z,,0,0,0900006482b61cc0